- MEK/ERK and PI3K/AKT pathway inhibitors affect the transformation of myelodysplastic syndrome into acute myeloid leukemia via H3K27me3 methylases and de‑methylases
Zhuanzhen Zheng et al, 2023, International Journal of Oncology CrossRef - Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells
Merve Şansaçar et al, 2023, Medical Oncology CrossRef